Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/8263
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCostelli, Paolacat
dc.contributor.authorCarbó Carbó, Neuscat
dc.contributor.authorTessitore, Lucianacat
dc.contributor.authorBagby, Gregory J.cat
dc.contributor.authorLópez-Soriano, Francisco J.cat
dc.contributor.authorArgilés Huguet, Josep Ma.cat
dc.contributor.authorBaccino, Francesco M.cat
dc.date.accessioned2009-05-14T10:14:17Z-
dc.date.available2009-05-14T10:14:17Z-
dc.date.issued1993cat
dc.identifier.issn0021-9738cat
dc.identifier.urihttp://hdl.handle.net/2445/8263-
dc.description.abstractRats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.eng
dc.format.extent7 p.cat
dc.format.mimetypeapplication/pdfeng
dc.language.isoengeng
dc.publisherAmerican Society for Clinical Investigationcat
dc.relation.isformatofReproducció del document publicat a http://dx.doi.org/doi:10.1172/JCI116897cat
dc.relation.ispartofJournal of Clinical Investigation, 1993, vol. 92, núm. 6, p. 2783-2789.cat
dc.rights(c) The American Society for Clinical Investigation, 1993cat
dc.sourceArticles publicats en revistes (Bioquímica i Biomedicina Molecular)-
dc.subject.classificationTumorscat
dc.subject.classificationNecrosicat
dc.subject.classificationMúsculscat
dc.subject.otherTumor necrosis factoreng
dc.subject.otherSkeletal muscleeng
dc.subject.otherProtein turnovereng
dc.titleTumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.eng
dc.typeinfo:eu-repo/semantics/articleeng
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec79740cat
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid8254032-
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
79740.pdf1.28 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.